Literature DB >> 25490709

Association of blood pressure and coronary collateralization in type 2 diabetic and nondiabetic patients with stable angina and chronic total occlusion.

Ying Shen1, Feng Hua Ding, Feng Wu, Lin Lu, Rui Yan Zhang, Qi Zhang, Zong Gui Wu, Wei Feng Shen.   

Abstract

OBJECTIVE: We investigated whether and to what extent blood pressure (BP) affects coronary collateralization in type 2 diabetic and nondiabetic patients with stable angina and chronic total occlusion.
METHODS: Brachial BP was measured using an inflatable cuff manometer in 431 diabetic and 287 nondiabetic patients with stable angina and angiographic total occlusion of at least one major coronary artery. They were classified according to the SBP (<100, 100-119, 120-139, 140-159, 160-179, and ≥180 mmHg), DBP (<60, 60-69, 70-79, 80-89, 90-99, and ≥100 mmHg), and pulse (<40, 40-49, 50-59, 60-69, 70-79, and ≥80 mmHg) BP ranges. The degree of coronary collaterals supplying the distal aspect of a total occlusion from the contralateral vessel was graded as poor (Rentrop score of 0 or 1) or good collateralization (Rentrop score of 2 or 3).
RESULTS: In diabetic patients, the incidence of poor collateralization was related to the DBP in a U-shaped pattern, with the lowest risk at 80-89 mmHg. In nondiabetic patients, an optimal DBP range was 90-99 mmHg for good collaterals, but no U-shaped relation between DBP and coronary collateralization was observed. After adjusting for the baseline characteristics in the logistic regression models, the increased risk of poor collateralization persisted for low or high DBP ranges in diabetic [odds ratio (OR) 2.02-7.29, P ≤ 0.04] and nondiabetic patients (OR 3.62-5.98, P ≤ 0.02). No such relations were observed between collateral grades and SBP and pulse BP.
CONCLUSION: This study demonstrates that 80-89 and 90-99 mmHg are the optimal ranges for DBP in diabetic and nondiabetic patients with stable angina and chronic total occlusion, within which the risk of poor collateralization is low.

Entities:  

Mesh:

Year:  2015        PMID: 25490709     DOI: 10.1097/HJH.0000000000000455

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study.

Authors:  Tong Liu; Zheng Wu; Jinghua Liu; Yun Lv; Wenzheng Li
Journal:  Cardiovasc Diabetol       Date:  2021-05-10       Impact factor: 9.951

2.  Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.

Authors:  Ying Shen; Feng Hua Ding; Rui Yan Zhang; Qi Zhang; Lin Lu; Wei Feng Shen
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

Review 3.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

4.  Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Zhen Kun Yang; Jian Hu; Xiao Qun Wang; Yang Dai; Su Zhang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-06-01       Impact factor: 9.951

Review 5.  Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease.

Authors:  Ying Shen; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2019-11-16       Impact factor: 9.951

Review 6.  Diabetic dyslipidemia impairs coronary collateral formation: An update.

Authors:  Ying Shen; Xiao Qun Wang; Yang Dai; Yi Xuan Wang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Front Cardiovasc Med       Date:  2022-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.